|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Accium BioSciences, Inc. And Radiant Research Forge Strategic Co-Marketing Agreement
10/19/2005 5:09:01 PM
SEATTLE--(BUSINESS WIRE)--June 16, 2005--Accium BioSciences, Inc. (Accium), the first US company to develop a fully commercial analytical facility dedicated to Accelerator Mass Spectrometry (AMS) services, has forged a new strategic co-marketing agreement with Radiant Research, Inc. (Radiant). This agreement combines Accium's expertise in AMS-based study design and in-house analytical services with Radiant's state-of-the-art clinical trials facilities to provide pharmaceutical researchers with comprehensive Phase 0 (microdosing) and low radiation Phase I clinical services nationwide.
"For the first time, this partnership provides our pharmaceutical sponsors with a one-stop solution for both the clinical and analytical components of early phase clinical trials," stated Ali Arjomand, Ph.D., President and Chief Operating Officer of Accium BioSciences. "Radiant is leading the way in early phase clinical trial services in the US and Accium is pleased to be working with Radiant's experienced investigators, research professionals and business development teams."
|
|
|
|
|
|
|
|
|
|
|